The antibody-based CA125-targeted maintenance therapy for the epithelial ovarian cancer: a meta-analysis.

CONCLUSIONS: CA125-targeted antibody used as maintenance therapy alone is not more effective than placebo but they were safe as maintenance therapy. PMID: 29894066 [PubMed - in process]
Source: European Journal of Gynaecological Oncology - Category: OBGYN Tags: Eur J Gynaecol Oncol Source Type: research